Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Am J Physiol Renal Physiol ; 319(4): F674-F685, 2020 10 01.
Article in English | MEDLINE | ID: mdl-32830540

ABSTRACT

C57BL/6 mice are one of the most commonly used mouse strains in research, especially in kidney injury studies. However, C57BL/6 mice are resistant to chronic kidney disease-associated pathologies, particularly the development of glomerulosclerosis and interstitial fibrosis. Our laboratory and others developed a more clinically relevant dosing regimen of cisplatin (7 mg/kg cisplatin once a week for 4 wk and mice euthanized at day 24) that leads to the development of progressive kidney fibrosis in FVB/n mice. However, we found that treating C57BL/6 mice with this same dosing regimen does not result in kidney fibrosis. In this study, we demonstrated that increasing the dose of cisplatin to 9 mg/kg once a week for 4 wk is sufficient to consistently induce fibrosis in C57BL/6 mice while maintaining animal survival. In addition, we present that cohorts of C57BL/6 mice purchased from Jackson 1 yr apart and mice bred in-house display variability in renal outcomes following repeated low-dose cisplatin treatment. Indepth analyses of this intra-animal variability revealed C-C motif chemokine ligand 2 as a marker of cisplatin-induced kidney injury through correlation studies. In addition, significant immune cell infiltration was observed in the kidney after four doses of 9 mg/kg cisplatin, contrary to what has been previously reported. These results indicate that multiple strains of mice can be used with our repeated low-dose cisplatin model with dose optimization. Results also indicate that littermate control mice should be used with this model to account for population variability.


Subject(s)
Acute Kidney Injury/chemically induced , Chemokine CCL2/metabolism , Cisplatin , Kidney/metabolism , Acute Kidney Injury/immunology , Acute Kidney Injury/metabolism , Acute Kidney Injury/pathology , Animals , Apoptosis , Chemokine CCL2/genetics , Chemotaxis, Leukocyte , Disease Models, Animal , Endoplasmic Reticulum Stress , Fibrosis , Kidney/immunology , Kidney/pathology , Macrophages/immunology , Macrophages/metabolism , Male , Mice, Inbred C57BL , Monocytes/immunology , Monocytes/metabolism , Necrosis , Signal Transduction , Species Specificity
2.
Sci Rep ; 9(1): 15077, 2019 10 21.
Article in English | MEDLINE | ID: mdl-31636296

ABSTRACT

The complex interactions between subclinical changes to hepatic extracellular matrix (ECM) in response to injury and tumor-associated macrophage microenvironmental cues facilitating metastatic cell seeding remain poorly understood. This study implements a combined computational modeling and experimental approach to evaluate tumor growth following hepatic injury, focusing on ECM remodeling and interactions with local macrophages. Experiments were performed to determine ECM density and macrophage-associated cytokine levels. Effects of ECM remodeling along with macrophage polarization on tumor growth were evaluated via computational modeling. For primary or metastatic cells in co-culture with macrophages, TNF-α levels were 5× higher with M1 vs. M2 macrophages. Metastatic cell co-culture exhibited 10× higher TNF-α induction than with primary tumor cells. Although TGFß1 induction was similar between both co-cultures, levels were slightly higher with primary cells in the presence of M1. Simulated metastatic tumors exhibited decreased growth compared to primary tumors, due to high local M1-induced cytotoxicity, even in a highly vascularized microenvironment. Experimental analysis combined with computational modeling may provide insight into interactions between ECM remodeling, macrophage polarization, and liver tumor growth.


Subject(s)
Computer Simulation , Extracellular Matrix/pathology , Liver Neoplasms/secondary , Liver/injuries , Macrophages/pathology , Animals , Cell Differentiation/drug effects , Cell Line, Tumor , Cell Movement/drug effects , Cell Proliferation/drug effects , Extracellular Matrix/drug effects , Female , Liver/pathology , Liver Neoplasms/pathology , Macrophages/drug effects , Male , Mice, Inbred C57BL , Neovascularization, Physiologic/drug effects , Transforming Growth Factor beta1/pharmacology , Tumor Burden/drug effects , Tumor Necrosis Factor-alpha/pharmacology
3.
Sci Rep ; 9(1): 4177, 2019 03 12.
Article in English | MEDLINE | ID: mdl-30862796

ABSTRACT

The tumor microenvironment (TME) is composed of a heterogeneous biological ecosystem of cellular and non-cellular elements including transformed tumor cells, endothelial cells, immune cells, activated fibroblasts or myofibroblasts, stem and progenitor cells, as well as the cytokines and matrix that they produce. The constituents of the TME stroma are multiple and varied, however cancer associated fibroblasts (CAF) and their contribution to the TME are important in tumor progression. CAF are hypothesized to arise from multiple progenitor cell types, including mesenchymal stem cells. Currently, isolation of TME stroma from patients is complicated by issues such as limited availability of biopsy material and cell stress incurred during lengthy adaptation to atmospheric oxygen (20% O2) in cell culture, limiting pre-clinical studies of patient tumor stromal interactions. Here we describe a microenvironment mimetic in vitro cell culturing system that incorporates elements of the in vivo lung environment, including lung fibroblast derived extracellular matrix and physiological hypoxia (5% O2). Using this system, we easily isolated and rapidly expanded stromal progenitors from patient lung tumor resections without complex sorting methods or growth supplements. These progenitor populations retained expression of pluripotency markers, secreted factors associated with cancer progression, and enhanced tumor cell growth and metastasis. An understanding of the biology of these progenitor cell populations in a TME-like environment may advance our ability to target these cells and limit their effects on promoting cancer metastasis.


Subject(s)
Lung Neoplasms/pathology , Mesenchymal Stem Cells/pathology , Tumor Microenvironment , Aged , Animals , Biomarkers, Tumor/metabolism , Biopsy , Cell Communication , Cell Hypoxia , Cell Lineage , Cell Proliferation , Cell Separation , Female , Humans , Immunophenotyping , Male , Mice , Middle Aged , Neoplasm Metastasis , Stromal Cells/metabolism , Tumor Cells, Cultured
SELECTION OF CITATIONS
SEARCH DETAIL
...